The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
SalplusF Inhaler 125/25 fluticasone propionate/salmeterol (as xinafoate) 125 microgram/25 microgram inhalation pressurised aerosol can metered dose (267104)
ARTG Name
SalplusF Inhaler 125/25 fluticasone propionate/salmeterol (as xinafoate) 125 microgram/25 microgram inhalation pressurised aerosol can metered dose
Product name
SalplusF Inhaler 125/25 fluticasone propionate/salmeterol (as xinafoate) 125 microgram/25 microgram inhalation pressurised aerosol can metered dose
ARTG Date
Registration Type
Medicine
Therapeutic good type
Medicine
Sponsor
Ingredients
fluticasone propionate
salmeterol xinafoate
Licence category
RE
Licence status
A
Summary
Product Information
Consumer Medicine Information